[
  {
    "ts": null,
    "headline": "HALO vs. AMGN: Which Stock Is the Better Value Option?",
    "summary": "HALO vs. AMGN: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=e1b2af28f7676fa027e587a48699b9194a5618d140bb627a6b91100685e89aa5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741707608,
      "headline": "HALO vs. AMGN: Which Stock Is the Better Value Option?",
      "id": 133185012,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "HALO vs. AMGN: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=e1b2af28f7676fa027e587a48699b9194a5618d140bb627a6b91100685e89aa5"
    }
  },
  {
    "ts": null,
    "headline": "These 10 stocks beating the market’s recent Trump slump have this in common",
    "summary": "These 10 stocks beating the market’s recent Trump slump have this in common",
    "url": "https://finnhub.io/api/news?id=e8383f6a57268bab0c9cf132cc1de00ab367c29c1676d860b3901c1a8d646442",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741700400,
      "headline": "These 10 stocks beating the market’s recent Trump slump have this in common",
      "id": 133136678,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "These 10 stocks beating the market’s recent Trump slump have this in common",
      "url": "https://finnhub.io/api/news?id=e8383f6a57268bab0c9cf132cc1de00ab367c29c1676d860b3901c1a8d646442"
    }
  },
  {
    "ts": null,
    "headline": "BMEZ: Recession Fears Making You Sick? Buy This High-Yield Healthcare Fund",
    "summary": "BlackRock Health Sciences Term Trust is a top pick for high-yield dividends in healthcare. Click here to find out why BMEZ stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=0a90bbc72c21544b52437a24252fdcd27158f61d0b5128e17ea6b2ed0058f641",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741698125,
      "headline": "BMEZ: Recession Fears Making You Sick? Buy This High-Yield Healthcare Fund",
      "id": 133136036,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2148098716/image_2148098716.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "BlackRock Health Sciences Term Trust is a top pick for high-yield dividends in healthcare. Click here to find out why BMEZ stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=0a90bbc72c21544b52437a24252fdcd27158f61d0b5128e17ea6b2ed0058f641"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Files Three IPR Petitions Challenging Bristol-Myers Squibb Anti-PD1 And Anti-CTLA-4 Antibody Combination Method Of Treatment Patents",
    "summary": "On February 28, Amgen, Inc. filed three petitions for inter partes review, challenging the validity of all claims in three patents assigned to Bristol-Myers Squibb Co. . The claims of all three...",
    "url": "https://finnhub.io/api/news?id=24ef298c271873f3a1466ab7d51933f551422d33d5a15e6519fbf7ec05a746d3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741666090,
      "headline": "Amgen Files Three IPR Petitions Challenging Bristol-Myers Squibb Anti-PD1 And Anti-CTLA-4 Antibody Combination Method Of Treatment Patents",
      "id": 133130479,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "On February 28, Amgen, Inc. filed three petitions for inter partes review, challenging the validity of all claims in three patents assigned to Bristol-Myers Squibb Co. . The claims of all three...",
      "url": "https://finnhub.io/api/news?id=24ef298c271873f3a1466ab7d51933f551422d33d5a15e6519fbf7ec05a746d3"
    }
  }
]